Immunotherapy in prostate cancer: current state and future perspectives

Metastatic castrate resistant prostate cancer (PCa) remains an incurable entity. In the era of immunotherapy, the complex PCa microenvironment poses a unique challenge to the successful application of this class of agents. However, in the last decade, a tremendous effort has been made to explore thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Handa, Shivani, Hans, Bandhul, Goel, Shokhi, Bashorun, Hafis O., Dovey, Zach, Tewari, Ashutosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476347/
https://www.ncbi.nlm.nih.gov/pubmed/32952615
http://dx.doi.org/10.1177/1756287220951404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476347/
https://www.ncbi.nlm.nih.gov/pubmed/32952615
http://dx.doi.org/10.1177/1756287220951404

Ejemplares similares